QGEN — QIAGEN NV

Ownership history in McIlrath & Eck, LLC  ·  3 quarters on record

This page tracks every 13F SEC filing in which McIlrath & Eck, LLC reported a position in QIAGEN NV (QGEN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 UNCHANGED 65 — 0% 0.00% $3K $44.68
2025 Q2 UNCHANGED 65 — 0% 0.00% $3K $47.81
2025 Q1 INITIATED 65 — — 0.00% $3K $39.94
% of Fund (quarterly)    QGEN price (monthly, adj. close)

Other funds also holding QGEN

As of 2025 Q4 — sorted by position size

NUANCE INVESTMENTS, LLC 3Y 7Y 3.98% Nitorum Capital, L.P. 3Y 7Y 2.43% PRENTISS SMITH & CO INC 3Y 7Y 2.31% Parkman Healthcare Partners LLC 3Y 2.12% DNCA FINANCE 1.83% Perbak Capital Partners LLP 1.32% Ilex Capital Partners (UK) LLP 1.31% EARNEST PARTNERS LLC 3Y 7Y 0.81% Moors & Cabot, Inc. 3Y 7Y 0.64% Arbejdsmarkedets Tillaegspension 0.58%
← Back to McIlrath & Eck, LLC Holdings